Shane Clark, DO Office and Other Patient Information
Shane Clark, DO Biography and Info
Dr. Shane Clark is a hematologist and medical oncologist who is also board-certified in internal medicine. He completed his residency and fellowship training at McLaren Health Care/Michigan State University, where he was chosen as Chief Resident during his internal medicine residency and Chief Fellow during his hematology and medical oncology fellowship. He developed a love for this field as it provides an opportunity and responsibility to work with a highly skilled multidisciplinary team to deploy the latest evidence-based treatment for his patients. He strongly believes in the principles of active listening and shared decision-making as two fundamental pillars of the doctor-patient relationship, and looks forward to working with patients during their medical journey. His areas of expertise include:
- Lung Cancer
- Breast Cancer
- Genitourinary Cancer
- Gastrointestinal Cancer
- Benign Hematologic Disorders
- Chronic Hematologic Malignancies
About Me
I was born and raised outside of Orlando, Florida. After completing my postgraduate training in Michigan, I was eager to return to the Sunshine State and replace my snow shovel with a beach umbrella. My wife and I enjoy exploring the wonderful food scene that Jacksonville provides, as well as regularly playing golf with friends and family in the area. If the weather calls for indoor living, then I very much enjoy reading a variety of books and articles as well as cooking new recipes and foods with my wife.
For me, becoming a physician has been a dream manifested into reality. It allows me to connect with a wide variety of people and help them during a time in their lives that can be difficult. It provides me an opportunity to make a positive impact in the lives of my patients as well as the caregivers who support them outside of the clinic. I strongly believe in the principle of patient autonomy and understand that active listening is integral in the process of shared decision-making in order to develop a plan that is in line with the goals of my patients.
Specialties
- Hematology
- Medical Oncology
- Internal Medicine
Boards
- American Board of Internal Medicine (Medical Oncology)
- American Board of Internal Medicine (Internal Medicine)
- American Board of Internal Medicine (Hematology)
Languages
- English
Hospital Affiliation
- Baptist Medical Center Jacksonville
- Baptist Medical Center South
- Baptist Medical Center Clay
Legal Practice Name
- Baptist MD Anderson Cancer Physicians, Inc.
Ages Treated
- Adult
- Senior
Shane Clark, DO Additional Information
Education & Training
-
Doctor of Osteopathic Medicine - Medical School
Lake Erie College of Osteopathic Medicine - Bradenton , FL
2018
-
Residency
McLaren Greater Lansing - Lansing , MI
2018 – 2021
-
Fellowship
McLaren Greater Lansing
2021 – 2024
Publications
-
Opportunities and challenges of conducting vaccine research in low and middle-income countries in the Asia-Pacific region: perspectives from the Asia-Pacific Vaccine Research Network. PMID: 40475887
Thobari JA, Arguni E, Bunoan-Macazo JA, Clark S, Dorj N, Douangboupha V, Doungngern P, Vu HH, Chandra LA, Haposan JH, Koroituku I, Nouanthong P, Ong-Lim AL, Otgonbayar D, Tran LP, Tuibeqa I, von Mollendorf C, Russell FM
Lancet Reg Health West Pac 2025 May. 58101559 doi: 10.1016/j.lanwpc.2025.101559. Epub 2025 May 10.
PMID: 40475887 [PubMed]
-
Causes and consequences of 'delays' in the diagnosis of spinal dural arterio-venous fistula; An illustrative case series, review and commentary. PMID: 40466236
Chéné D, Clark S, Yull D, Yee J, Yau YH, Whittle IR
J Clin Neurosci 2025 Jun 3. 138111346 doi: 10.1016/j.jocn.2025.111346. Epub 2025 Jun 3.
PMID: 40466236 [PubMed - as supplied by publisher]
-
Web-Based Education Program for Care Partners of People Living With Dementia (iGeriCare): Protocol for a Pilot Randomized Controlled Trial. PMID: 40466093
Levinson AJ, Ayers S, Clark S, Woodburn R, Markle-Reid M, McKenna B, Oliver D, Papaioannou A, Siu H, Sztramko R
JMIR Res Protoc 2025 Jun 4. 14e67048 doi: 10.2196/67048. Epub 2025 Jun 4.
PMID: 40466093 [PubMed - indexed for MEDLINE]
-
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models. PMID: 40465424
Pagliarini RA, Henderson JA, Milgram BC, Borrelli DR, Brooijmans N, Hilbert BJ, Huff MR, Ito T, Kryukov GV, Ladd B, Martin BR, Motiwala H, O'Hearn E, Tsai CF, Wang W, Bellier J, Boland L, Clark S, Hensley E, Hata AN, Kuzmic P, Guzman-Perez A, Jackson EL, Stuart DD
Clin Cancer Res 2025 Jun 4. OF1-OF17 doi: 10.1158/1078-0432.CCR-24-3833. Epub 2025 Jun 4.
PMID: 40465424 [PubMed - as supplied by publisher]